Prognostic utility of inflammation-based biomarkers, neutrophil–lymphocyte ratio and change in neutrophil–lymphocyte ratio, in surgically resected lung cancers

Prognostic utility of inflammation-based biomarkers, neutrophil–lymphocyte ratio and change in neutrophil–lymphocyte ratio, in surgically resected lung cancers

BACKGROUND/OBJECTIVE: Given the poor overall survival (OR) and progression-free survival (PFS) rates for lung cancers managed with surgical resection, there is a need to identify the prognostic markers that would improve the risk stratification of patients with operable lung cancer to inform treatme...

Full description

Bibliographic Details
Main Authors: Daniel Thompson, Luke A Perry, Jesse Renouf, Domagoj Vodanovich, Adele Hwee Hong Lee, Jahan Dimiri, Gavin Wright
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Annals of Thoracic Medicine
Subjects:
cancer prognostication
lung cancer
neutrophil–lymphocyte ratio
Online Access:http://www.thoracicmedicine.org/article.asp?issn=1817-1737;year=2021;volume=16;issue=2;spage=148;epage=155;aulast=Thompson

Internet

http://www.thoracicmedicine.org/article.asp?issn=1817-1737;year=2021;volume=16;issue=2;spage=148;epage=155;aulast=Thompson

Similar Items